Next Article in Journal / Special Issue
Emerging Approach for the Application of Hibiscus sabdariffa Extract Ointment in the Superficial Burn Care
Previous Article in Journal
A Narrative Review of the Potential Roles of Lipid-Based Vesicles (Vesiculosomes) in Burn Management
Previous Article in Special Issue
In Vitro and In Silico Antistaphylococcal Activity of Indole Alkaloids Isolated from Tabernaemontana cymosa Jacq (Apocynaceae)
 
 
Article

Colorectal Cancer Chemoprevention by S-Allyl Cysteine–Caffeic Acid Hybrids: In Vitro Biological Activity and In Silico Studies

1
Chemistry of Colombian Plants Group, Institute of Chemistry, Faculty of Exact and Natural Sciences, University of Antioquia (UdeA), Calle 70 No. 52–21, A.A 1226, Medellin 050010, Colombia
2
Medical and Experimental Mycology Group, Corporación para Investigaciones Biológicas, Medellin 050034, Colombia
3
School of Health Sciences, Pontifical Bolivarian University, Medellin 050034, Colombia
*
Authors to whom correspondence should be addressed.
Academic Editor: Murali Mohan Yallapu
Sci. Pharm. 2022, 90(3), 40; https://doi.org/10.3390/scipharm90030040
Received: 4 April 2022 / Revised: 10 May 2022 / Accepted: 23 May 2022 / Published: 30 June 2022
(This article belongs to the Special Issue Feature Papers in Scientia Pharmaceutica)
Conventional chemotherapy for colorectal cancer (CRC) gives only a small increase in patient survival, since it is often diagnosed at late stages, when the tumor has disseminated to other organs. Moreover, it is common to observe that malignant cells may acquire resistance to conventional chemotherapies through different mechanisms, including reducing drug activation or accumulation (by enhancing efflux), inducing alterations in molecular targets, and inhibiting the DNA damage response, among other strategies. Considering these facts, the discovery of new molecules with therapeutic potential has become an invaluable tool in chemoprevention. In this context, we previously evaluated two hybrids (SAC-CAFA-MET and SAC-CAFA-PENT) that exhibited selective cytotoxicity against SW480 cells, with better results than the conventional chemotherapeutic agent (5-fluorouracil; 5-FU). Here, we investigated the possible mechanisms of these molecules in greater depth, to identify whether they could be valuable therapeutic scaffolds in the search for new molecules with chemopreventive potential for the treatment of CRC. Both compounds reduced ROS formation, which could be related to antioxidant effects. Further evaluations showed that SAC-CAFA-MET induces cell death independent of caspases and the tumor-suppressor protein p53, but probably mediated by the negative regulation of the pro-apoptotic Bcl-2. In addition, the lack of activation of caspase-8 and the positive regulation of caspase-3 induced by SAC-CAFA-PENT suggest that this compound acts through an apoptotic mechanism, probably initiated by intrinsic pathways. Furthermore, the downregulation of IL-6 by SAC-CAFA-PENT suggests that it also induces a significant anti-inflammatory process. In addition, docking studies would suggest caspase-3 modulation as the primary mechanism by which SAC-CAFA-PENT elicits apoptosis in SW480human colorectal adenocarcinoma cells. Meanwhile, density functional theory (DFT) calculations suggest that both hybrids would produce effects in the modulation of ROS in SW480 cells via the hydrogen atom transfer (HAT) pathway. The present work notes that SAC-CAFA-MET and SAC-CAFA-PENT could be potential candidates for further investigations in the search for potential chemopreventive agents. View Full-Text
Keywords: S-allyl cysteine; caffeic acid; hybrid compounds; chemoprevention; colorectal cancer; cell death; apoptosis; anti-inflammation; antioxidant; in silico; docking S-allyl cysteine; caffeic acid; hybrid compounds; chemoprevention; colorectal cancer; cell death; apoptosis; anti-inflammation; antioxidant; in silico; docking
Show Figures

Figure 1

MDPI and ACS Style

Herrera-Ramirez, A.; Yepes-Pérez, A.F.; Quintero-Saumeth, J.; Moreno-Quintero, G.; Naranjo, T.W.; Cardona-Galeano, W. Colorectal Cancer Chemoprevention by S-Allyl Cysteine–Caffeic Acid Hybrids: In Vitro Biological Activity and In Silico Studies. Sci. Pharm. 2022, 90, 40. https://doi.org/10.3390/scipharm90030040

AMA Style

Herrera-Ramirez A, Yepes-Pérez AF, Quintero-Saumeth J, Moreno-Quintero G, Naranjo TW, Cardona-Galeano W. Colorectal Cancer Chemoprevention by S-Allyl Cysteine–Caffeic Acid Hybrids: In Vitro Biological Activity and In Silico Studies. Scientia Pharmaceutica. 2022; 90(3):40. https://doi.org/10.3390/scipharm90030040

Chicago/Turabian Style

Herrera-Ramirez, Angie, Andres F. Yepes-Pérez, Jorge Quintero-Saumeth, Gustavo Moreno-Quintero, Tonny W. Naranjo, and Wilson Cardona-Galeano. 2022. "Colorectal Cancer Chemoprevention by S-Allyl Cysteine–Caffeic Acid Hybrids: In Vitro Biological Activity and In Silico Studies" Scientia Pharmaceutica 90, no. 3: 40. https://doi.org/10.3390/scipharm90030040

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop